Reply to comment on Peto et al. (2020): Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic
An epidemic model is a hypothesis, not an observation. Few scientists would question our statement that the impact of ‘the combination of weekly SARS-CoV-2 testing with an earlier test if symptoms appear, strict household quarantine and contact tracing … cannot be reliably predicted by further modelling’ [1, p. 3]; yet Planck and colleagues [2] claim that their simple model shows that mass weekly testing and household quarantine, even if it were perfectly achievable, would not be sufficient to control the spread of COVID-19. This is contradicted by the transient reversal of rising prevalence in Slovakia after two rounds of weekly national testing and household quarantine. Prevalence fell by 58% within a week, and a microsimulation calibrated to the observed results confirms that quarantining the whole household following a positive test made a dominant contribution, with an estimated weekly reduction in the prevalence of 59% with and only 10% without household quarantine [3]. We need real data on the effects of different population testing protocols in whole cities [4], not uncalibrated simulations predicting that it cannot work.
Footnotes
References
- 1.
Peto J . 2020Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic. R. Soc. Open Sci. 7, 200915. (doi:10.1098/rsos.200915) Link, ISI, Google Scholar - 2.
Plank MJ, James A, Steyn N . 2021Comment: Weekly COVID-19 testing with household quarantine and contact tracing is feasible and would probably end the epidemic. R. Soc. Open Sci. 8, 201546. (doi:10.1098/rsos.201546) Link, ISI, Google Scholar - 3.
Pavelka M . 2020The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia. Science 372, 635-641. (doi:10.1126/science.abf9648) Crossref, ISI, Google Scholar - 4.
Peto J, Hunter DJ, Riboli E, Griffin JL . 2020Unnecessary obstacles to COVID-19 mass testing. Lancet 396, 1633. (doi:10.1016/S0140-6736(20)32170-X) Crossref, PubMed, ISI, Google Scholar


